![BIGBEAR Pharmaceutical объявляет об одобрении биниметиниба[Binimetinib] и энкорафениба[Encorafenib] в Лаосе](https://lienteh.net/wp-content/uploads/2024/10/2024-10-1274-150x150.webp "BIGBEAR Pharmaceutical объявляет об одобрении биниметиниба[Binimetinib] и энкорафениба[Encorafenib] в Лаосе")
Vientiane, Laos - October 12 2024 - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer treatments, today announced that Binimetinib…
Read More
Vientiane, Laos - September 20, 2024 - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer treatments, today announced that…
Read More
Вьентьян, Лаос - 12 октября 2024 г. - BigBear Pharma, ведущая биофармацевтическая компания, занимающаяся разработкой и коммерциализацией инновационных методов лечения рака, сегодня объявила, что…
Read MoreIntroduction If you are looking for new business opportunities in the pharmaceutical industry, there is a product for you: Generic Mitotane sold under the brand…
Read More
Вьентьян, Лаос – 8 апреля 2024 г. – BigBear Pharma, ведущая биофармацевтическая компания, занимающаяся разработкой и коммерциализацией инновационных методов лечения рака, сегодня объявила, что…
Read More
О препарате Aumolertinib Aumolertinib (ранее известный как almonertinib) — это ингибитор тирозинкиназы EGFR, нацеленный на сенсибилизирующие мутации EGFR…
Acerca de Aumolertinib Aumolertinib (anteriormente conocido como almonertinib) es un inhibidor de la tirosina quinasa del EGFR que…
About Vemurafenib Vemurafenib is a medication used for the treatment of late-stage melanoma. It is an inhibitor of the B-Raf enzyme. Malignant…
About Ribociclib Ribociclib is a targets proteins called cyclin dependant kinase 4 and cyclin dependant 6 (CDK…
About Alpelisib Alpelisib is a medication used to treat certain types of breast cancer. It is used together with fulvestrant. It is…
About Sunitinib Sunitinib is an anti-cancer medication. It is a small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved…
About Asciminib Asciminib is a medication used to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Asciminib is a protein kinase inhibitor. Chronic Myeloid…
About Quizartinib Quizartinib is an anti-cancer medication used for the treatment of acute myeloid leukemia. It is a small molecule receptor…
About Ponatinib Ponatinib is a medication used for the treatment of chronic myeloid leukemia and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia. It…
About Pirtobrutinib Pirtobrutinib is an inhibits B cell lymphocyte proliferation and survival by binding and inhibiting Bruton's tyrosine…
Copyright © 2021-2022 LienTeh.net All rights reserved.
